Transforming growth factor beta 1 potently activates CPP32-like proteases in human hepatoma cells

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Transforming growth factor beta 1 (TGF-β1) is a key regulator of cellular processes, including apoptosis.
• Apoptosis, or programmed cell death, is crucial for development and tissue homeostasis.
• Hep3B hepatoma cells are a relevant model for studying liver cancer cell death pathways.

Purpose of the Study:

• To investigate the role of caspases in TGF-β1-induced apoptosis in Hep3B cells.
• To identify specific caspases involved in the apoptotic pathway triggered by TGF-β1.
• To elucidate the molecular mechanisms underlying TGF-β1-mediated cell death.

Main Methods:

• Induction of apoptosis in Hep3B cells using TGF-β1.
• Treatment with broad-specificity (ZVAD-FMK) and specific (DEVD-FMK) caspase inhibitors.
• Assay of caspase activity.
• Immunoblotting to detect poly(ADP-ribose) polymerase (PARP) cleavage.

Main Results:

• TGF-β1 treatment induced apoptosis in Hep3B cells.
• Caspase activation, including caspase-3-like proteases, was observed during TGF-β1-induced apoptosis.
• Caspase inhibitors blocked TGF-β1-induced apoptosis in a dose-dependent manner.
• Cleavage of PARP, a known caspase substrate, was confirmed in TGF-β1-treated cells.

Conclusions:

• Caspase activation, particularly by caspase-3-like proteases, is essential for TGF-β1-induced apoptosis in Hep3B hepatoma cells.
• These findings highlight the critical role of specific caspases in mediating TGF-β1-driven cell death in liver cancer cells.
• Targeting these caspase pathways may offer therapeutic strategies for hepatocellular carcinoma.